文献速递慢性肾脏病血液净化与透析

尿毒症性菌群失调促进胰岛素抵抗与肌少症

Contribution of uremic dysbiosis to insulin resistance and sarcopenia.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究在腺嘌呤饮食诱导的CKD小鼠中,通过粪菌移植将CKD小鼠盲肠菌群移植给无菌小鼠,发现CKD-FMT小鼠重现胰岛素抵抗和肌少症,伴肠道紧密连接蛋白表达下降、脂肪细胞变小、全身微炎症及血清尿毒症溶质升高。结论提示尿毒症性菌群失调可诱导胰岛素抵抗、肌少症、肠漏和脂肪营养不良。

要点

  • CKD小鼠存在胰岛素抵抗和肌少症,其菌群移植可重现该表型。
  • CKD-FMT小鼠出现肠漏、脂肪萎缩、微炎症和尿毒症溶质升高。
  • 尿毒症性菌群失调是CKD相关胰岛素抵抗和肌少症的驱动因素。

核心结论

  • 尿毒症性菌群失调可诱导胰岛素抵抗、肌少症、肠漏和脂肪营养不良。

研究设计与样本

  • Specific pathogen-free小鼠经含腺嘌呤饮食诱导CKD,对照喂正常饮食。
  • 将对照或CKD小鼠盲肠菌群经口灌胃移植给健康无菌小鼠,设无菌PBS灌胃对照。
  • 接种2周后评估胰岛素抵抗和肌少症等表型。

主要发现

  • CKD小鼠较对照出现胰岛素抵抗和肌少症。
  • CKD-FMT小鼠较control-FMT和vehicle小鼠重现胰岛素抵抗和肌少症,伴骨骼肌胰岛素信号转导减弱和线粒体功能障碍。
  • CKD-FMT小鼠肠道紧密连接蛋白表达和脂肪细胞大小低于control-FMT小鼠。
  • CKD-FMT小鼠出现全身微炎症、血清尿毒症溶质浓度升高、粪便细菌发酵产物增加及骨骼肌脂质含量升高。
  • CKD与对照小鼠的肠道菌群差异在CKD-FMT与control-FMT小鼠间基本一致。

临床怎么用

  • 提示调节尿毒症性菌群失调可能成为改善CKD患者胰岛素抵抗和肌少症的潜在策略。

局限性

  • 研究为小鼠模型,结论外推至人类CKD患者需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) leads to insulin resistance (IR) and sarcopenia, which are associated with a high mortality risk in CKD patients; however, their pathophysiologies remain unclear. Recently, alterations in gut microbiota have been reported to be associated with CKD. We aimed to determine whether uremic dysbiosis contributes to CKD-associated IR and sarcopenia. METHODS: CKD was induced in specific pathogen-free mice via an adenine-containing diet; control animals were fed a normal diet. Fecal microbiota transplantation (FMT) was performed by oral gavage in healthy germ-free mice using cecal bacterial samples obtained from either control mice (control-FMT) or CKD mice (CKD-FMT). Vehicle mice were gavaged with sterile phosphate-buffered saline. Two weeks after inoculation, mice phenotypes, including IR and sarcopenia, were evaluated. RESULTS: IR and sarcopenia were evident in CKD mice compared with control mice. These features were reproduced in CKD-FMT mice compared with control-FMT and vehicle mice with attenuated insulin-induced signal transduction and mitochondrial dysfunction in skeletal muscles. Intestinal tight junction protein expression and adipocyte sizes were lower in CKD-FMT mice than in control-FMT mice. Furthermore, CKD-FMT mice showed systemic microinflammation, increased concentrations of serum uremic solutes, fecal bacterial fermentation products and elevated lipid content in skeletal muscle. The differences in gut microbiota between CKD and control mice were mostly consistent between CKD-FMT and control-FMT mice. CONCLUSIONS: Uremic dysbiosis induces IR and sarcopenia, leaky gut and lipodystrophy.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Uchiyama K, Wakino S, Irie J, et al. Contribution of uremic dysbiosis to insulin resistance and sarcopenia. Nephrol Dial Transplant. 2020. PMID: 32535631. doi:10.1093/ndt/gfaa076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。